Chronic imipramine treatment sensitizes 5-HT1A and 5-HT 2 A receptors in the dorsal periaqueductal gray matter: evidence from the elevated T-maze test of anxiety. (Q46709719)
Jump to navigation
Jump to search
scientific article published in November 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Chronic imipramine treatment sensitizes 5-HT1A and 5-HT 2 A receptors in the dorsal periaqueductal gray matter: evidence from the elevated T-maze test of anxiety. |
scientific article published in November 2005 |
Statements
Chronic imipramine treatment sensitizes 5-HT1A and 5-HT 2 A receptors in the dorsal periaqueductal gray matter: evidence from the elevated T-maze test of anxiety (English)
R L Nogueira
1 November 2005